Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway
暂无分享,去创建一个
A. Ashworth | A. Bardelli | P. Seneci | D. Delia | C. Lord | H. Walczak | D. Lecis | Maria Teresa Majorini | Carlotta Cancelliere | A. Conti | R. Elliott